Full Text
PIN29 Cost-Effectiveness of Nirsevimab Against Respiratory Syncytial VIRUS (RSV) Among US Infants Experiencing Their First RSV Season

Abstract

Authors

M. Beuvelet K. Chung-Delgado A. Kieffer

Back to Volume 24, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×